Regulation of T cells in airway disease by beta-agonist

Frontiers in Bioscience - Scholar

Volumn 2 S, Issue 3, 2010, Pages 969-979

  Loza, Matthew J ^a   Penn, Raymond B ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Airway Hyperresponsiveness; AKAP; Asthma; Beta 2 Adrenergic Receptor; Beta agonist; Bronchoalveolar Lavage; CD3; Inflammation; Interferon; Interleukin; JAK; MAPK; NF AT; NF kappaB; Prostaglandin; Receptor; Review; T cell; Th2; Thl; ZAP 70

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYTOKINE; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL; ASTHMA; BIOLOGICAL MODEL; CELL CULTURE; DRUG EFFECT; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ADRENERGIC BETA-AGONISTS; ANIMALS; ASTHMA; CELLS, CULTURED; CYTOKINES; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 77956644353     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. E.K. Griffiths, J.M. Penninger: Communication between the TCR and integrins: role of the molecular adapter ADAP/Fyb/Slap. Curr Opin Immunol 14, 317-322 (2002) (Pubitemid 34327973)
2. A.E. Nel: T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse. J Allergy Clin Immunol 109, 758-770 (2002) (Pubitemid 34499506)
3. A.E. Nel, N. Slaughter: T-cell activation through the antigen receptor. Part 2: role of signaling cascades in T-cell differentiation, anergy, immune senescence, and development of immunotherapy. J Allergy Clin Immunol 109, 901-915(2002) (Pubitemid 34634297)
4. M.J. Loza, S.P. Peters, and R.B. Penn: Atopy, asthma, and experimental approaches based on the linear model of T cell maturation. Clin Exp Allergy 35, 8-17 (2005) (Pubitemid 40188264)
5. P. Borger, D.S. Postma, E. Vellenga, and H.F. Kauffman: Regulation of asthma-related T-cell cytokines by the cyclic AMP-dependent signalling pathway. Clin Exp Allergy 30, 920-926 (2000) (Pubitemid 30427032)
6. M.J. Loza, S. Foster, S.P. Peters, and R.B. Penn: Beta-agonists modulate T cell functions via direct actions on type 1 and type 2 cells. Blood 107, 2052-2060 (2006) (Pubitemid 43289390)
7. E.M. Aandahl, W.J. Moretto, P.A. Haslett, T. Vang, T. Bryn, K. Tasken, and D.F. Nixon: Inhibition of antigen-specific T cell proliferation and cytokine production by protein kinase A type I. J Immunol 169, 802-808 (2002) (Pubitemid 34753436)
8. M.M. Bartik, G.P. Bauman, W.H. Brooks, and T.L. Roszman: Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells. Cell Immunol 158, 116-130 (1994) (Pubitemid 24321637)
9. G.P. Bauman, M.M. Bartik, W.H. Brooks, and T.L. Roszman: Induction of cAMP-dependent protein kinase (PKA) activity in T cells after stimulation of the prostaglandin E2 or the beta-adrenergic receptors: relationship between PKA activity and inhibition of anti-CD3 monoclonal antibody-induced T cell proliferation. Cell Immunol 158, 182-194 (1994)
10. N. Benbernou, S. Esnault, H.C. Shin, H. Fekkar, and M. Guenounou: Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway. Immunology 91, 361-368 (1997) (Pubitemid 27304271)
11. V. Ganapathy, T. Gurlo, H.O. Jarstadmarken, and H. von Grafenstein: Regulation of TCR-induced IFN-gamma release from islet-reactive non-obese diabetic CD8(+) T cells by prostaglandin E(2) receptor signaling. Int Immunol 12, 851-860(2000) (Pubitemid 30410458)
12. D. Laxminarayana, A. Berrada, and G.M. Kammer: Early events of human T lymphocyte activation are associated with type I protein kinase A activity. J Clin Invest 92, 2207-2214 (1993) (Pubitemid 23333525)
13. M. Neumann, T. Grieshammer, S. Chuvpilo, B. Kneitz, M. Lohoff, A. Schimpl, B.R. Franza Jr., and E. Serfling: RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J 14, 1991-2004 (1995)
14. B.T. Gjertsen, G. Mellgren, A. Otten, E. Maronde, H.G. Genieser, B. Jastorff, O.K. Vintermyr, G.S. McKnight, and S.O. Doskeland: Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-1 beta action. J Biol Chem 270, 20599-20607 (1995)
15. H. Abrahamsen, G. Baillie, J. Ngai, T. Vang, K. Nika, A. Ruppelt, T. Mustelin, M. Zaccolo, M. Houslay, and K. Tasken: TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling. J Immunol 173, 4847-4858 (2004) (Pubitemid 39387765)
16. H. Kawasaki, G.M. Springett, N. Mochizuki, S. Toki, M. Nakaya, M. Matsuda, D.E. Housman, and A.M. Graybiel: A family of cAMP-binding proteins that directly activate Rapl. Science 282, 2275-2279 (1998) (Pubitemid 29004080)
17. T. Vang, K.M. Torgersen, V. Sundvold, M. Saxena, F.O. Levy, B.S. Skalhegg, V. Hansson, T. Mustelin, and K. Tasken: Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor. J Exp Med 193, 497-507 (2001) (Pubitemid 32524480)
18. A. Ruppelt, R. Mosenden, M. Gronholm, E.M. Aandahl, D. Tobin, CR. Carlson, H. Abrahamsen, F.W. Herberg, O. Carpen, and K. Tasken: Inhibition of T cell activation by cyclic adenosine 5'-monophosphate requires lipid raft targeting of protein kinase A type I by the A-kinase anchoring protein ezrin. J Immunol 179, 5159-5168 (2007)
19. N. Dumaz, R. Marais: Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras. J Biol Chem 278, 29819-29823 (2003) (Pubitemid 36962369)
20. C. Blanco-Aparicio, J. Torres, and R. Pulido: A novel regulatory mechanism of MAP kinases activation and nuclear translocation mediated by PKA and the PTP-SL tyrosine phosphatase. J Cell Biol 147, 1129-1136 (1999)
21. M. Saxena, S. Williams, K. Tasken, and T. Mustelin: Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase. Nat Cell Biol 1, 305-311 (1999) (Pubitemid 129495782)
22. M. Monfar, K.P. Lemon, T.C. Grammer, L. Cheatham, J. Chung, C.J. Vlahos, and J. Blenis: Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP. Mol Cell Biol 15, 326-337 (1995) (Pubitemid 24379930)
23. M.A. Alava, K.E. DeBell, A. Conti, T. Hoffman, and E. Bonvini: Increased intracellular cyclic AMP inhibits inositol phospholipid hydrolysis induced by perturbation of the T cell receptor/CD3 complex but not by G-protein stimulation. Association with protein kinase A-mediated phosphorylation of phospholipase C-gamma 1. Biochem J 284 (Pt 1), 189-199 (1992)
24. D.J. Park, H.K. Min, and S.G. Rhee: Inhibition of CD3-linked phospholipase C by phorbol ester and by cAMP is associated with decreased phosphotyrosine and increased phosphoserine contents of PLC-gamma 1. J Biol Chem 267, 1496-1501(1992)
25. C.W. Chow, R.J. Davis: Integration of calcium and cyclic AMP signaling pathways by 14-3-3. Mol Cell Biol 20, 702-712(2000) (Pubitemid 30023112)
26. C.W. Chow, M. Rincon, and R.J. Davis: Requirement for transcription factor NFAT in interleukin-2 expression. Mol Cell Biol 19, 2300-2307 (1999) (Pubitemid 29098287)
27. K.M. Torgersen, T. Vang, H. Abrahamsen, S. Yaqub, and K. Tasken: Molecular mechanisms for protein kinase A-mediated modulation of immune function. Cell Signal 14, 1-9 (2002) (Pubitemid 34020823)
28. H. Zhong, R.E. Voll, and S. Ghosh: Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1, 661-671 (1998) (Pubitemid 128379244)
29. M. Neumann, T. Grieshammer, S. Chuvpilo, B. Kneitz, M. Lohoff, A. Schimpl, B.R. Franza Jr., and E. Serfling: RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. Embo J 14, 1991-2004(1995)
30. F.D. Finkelman, D. Vercelli: Advances in asthma, allergy mechanisms, and genetics in 2006. J Allergy Clin Immunol 120, 544-550 (2007) (Pubitemid 47320758)
31. S.T. Holgate: Pathogenesis of asthma. Clin Exp Allergy SR, 872-897(2008)
32. M.T. Kasaian, D.K. Miller: IL-13 as a therapeutic target for respiratory disease. Biochem Pharmacol 76, 147-155 (2008)
33. A.M. Colavita, A.J. Reinach, and S.P. Peters: Contributing factors to the pathobiology of asthma. The Thl/Th2 paradigm. Clin Chest Med 21, 263-277, viii (2000) (Pubitemid 30434638)
34. M.J. Holtzman, D. Sampath, M. Castro, D.C. Look, and S. Jayaraman: The one-two of T helper cells: does interferon-gamma knock out the Th2 hypothesis for asthma? Am J Respir Cell Mol Biol 14, 316-318 (1996) (Pubitemid 126440496)
35. D.H. Broide: Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. J Allergy Clin Immunol 121, 560-570 (2008) (Pubitemid 351323873)
36. DA. Deshpande, R.B. Penn: Targeting G protein-coupled receptor signaling in asthma. Cell Signal 18, 2105-2120 (2006) (Pubitemid 44636173)
37. N. Agarwal, I. Nir, and D.S. Papermaster: Loss of diurnal arrestin gene expression in rds mutant mouse retinas. Exp Eye Res 58, 1-8 (1994) (Pubitemid 24071614)
38. M.R. Sears, D.R. Taylor, P. CG., D.C. Lake, Q. Li, E.M. Flannery, D.M. Yates, M.K. Lucas, and G.P. Herbison: Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 336, 1391-1396 (1990)
39. W.O. Spitzer, S. Suissa, P. Ernst, R.I. Horwitz, B. Habbick, D. Cockroft, J.-F. Boivin, M. McNutt, A.S. Buist, and A.S. Rebuck: The use of β-agonists and the risk of death and near-death from asthma. N EnglJ Med 326, 501-506(1992)
40. D.R. Taylor, G.I. Town, G.P. Herbison, D. Boothman-Burrell, E.M. Flannery, B. Hancox, E. Harre, K. Laubscher, V. Linscott, CM. Ramsay, and G. Richards: Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol. Thorax 53, 744-752 (1998) (Pubitemid 28408714)
41. E. Wooltorton: Salmeterol (Serevent) asthma trial halted early. Cmaj 168, 738. (2003) (Pubitemid 36363672)
42. LH. Heijink, B.M. van den, E. Vellenga, J.G. de Monchy, D.S. Postma, and H.F. Kauffman: Altered beta2-adrenergic regulation of T cell activity after allergen challenge in asthma. Clin Exp Allergy 34, 1356-1363 (2004) (Pubitemid 39233689)
43. H. Meurs, G.H. Koeter, V.K. de, and H.F. Kauffman: Dynamics of the lymphocyte beta-adrenoceptor system in patients with allergic bronchial asthma. Eur J Respir Dis Suppl 135, 47-61(1984) (Pubitemid 14137939)
44. H. Meurs, H.F. Kauffman, A. Timmermans, J.G. de Monchy, G.H. Koeter, and V.K. de: Specific immunological modulation of lymphocyte adenylate cyclase in asthmatic patients after allergenic bronchial provocation. IntArch Allergy Appl Immunol 81, 224-229 (1986) (Pubitemid 16004191)
45. LH. Heijink, E. Vellenga, J. Oostendorp, J.G. de Monchy, D.S. Postma, and H.F. Kauffman: Exposure to TARC alters beta2-adrenergic receptor signaling in human peripheral blood T lymphocytes. Am J Physiol Lung Cell Mol Physiol 289, L53-L59 (2005) (Pubitemid 40863554)
46. F. Westerhof, W. Timens, A. van Oosten, A.B. Zuidhof, N. Nauta, M. Schuiling, J.T. Vos, J. Zaagsma, H. Meurs, and W. Coers: Inflammatory cell distribution in guinea pig airways and its relationship to airway reactivity. Mediators Inflamm 10, 143-154(2001) (Pubitemid 32735307)
47. C. Sartori, X. Fang, D.W. McGraw, P. Koch, M.E. Snider, H.G. Folkesson, and MA Matthay: Selected contribution: long-term effects of beta(2)-adrenergic receptor stimulation on alveolar fluid clearance in mice. J Appl Physiol 93, 1875-1880 (2002) (Pubitemid 36083004)
48. M.A. Ferrada, E.L. Gordon, K.Y. Jen, H.Z. He, X. Lu, L.M. Barone, S. Amirifeli, D.L. Perkins, and P.W. Finn: (R)-albuterol decreases immune responses: role of activated T cells. Respir Res 9, 3 (2008)
49. P. Borger, Y. Hoekstra, M.T. Esselink, D.S. Postma, J. Zaagsma, E. Vellenga, and H.F. Kauffman: Beta-adrenoceptor-mediated inhibition of IFN-gamma, IL-3, and GM-CSF mRNA accumulation in activated human T lymphocytes is solely mediated by the beta2-adrenoceptor subtype. Am J Respir Cell Mol Biol 19, 400-407 (1998) (Pubitemid 128354209)
50. V.M. Sanders, R.A. Baker, D.S. Ramer-Quinn, D.J. Kasprowicz, B.A. Fuchs, and N.E. Street: Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J Immunol 158, 4200-4210 (1997) (Pubitemid 127483920)
51. E. Goleva, A. Dunlap, and D.Y. Leung: Differential control of TH1 versus TH2 cell responses by the combination of low-dose steroids with beta2-adrenergic agonists. J Allergy Clin Immunol 114, 183-191 (2004) (Pubitemid 39005136)
52. LH. Heijink, E. Vellenga, P. Borger, D.S. Postma, J.G. Monchy, and H.F. Kauffman: Polarized Lh1 and Lh2 cells are less responsive to negative feedback by receptors coupled to the AC/cAMP system compared to freshly isolated L cells. Br J Pharmacol 138, 1441-1450 (2003) (Pubitemid 36609639)
53. A.P. Kohm, V.M. Sanders: Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ L and B lymphocyte function in vitro and in vivo. Pharmacol Rev 53, 487-525 (2001) (Pubitemid 33138209)
54. M.J. Loza, B. Perussia: Peripheral immature CD2-/low L cell development from type 2 to type 1 cytokine production. J Immunol 169, 3061-3068 (2002) (Pubitemid 35013150)
55. D. Baramki, J. Koester, A.J. Anderson, and L. Borish: Modulation of L-cell function by (R)- and (S)-isomers of albuterol: anti-inflammatory influences of (R)-isomers are negated in the presence of the (S)-isomer. J Allergy Clin Immunol 109, 449-454 (2002) (Pubitemid 34234195)
56. J.W. Steinke, D. Baramki, and L. Borish: Opposing actions of (R, R)-isomers and (S, S)-isomers of formoterol on L-cell function. J Allergy Clin Immunol 118, 963-965(2006) (Pubitemid 44498767)
57. M.J. Loza, S.P. Peters, S. Foster, LU. Khan, and R.B. Penn: Beta-Agonist enhances type 2 L-cell survival and accumulation. J Allergy Clin Immunol 119, 235-244 (2007) (Pubitemid 46037809)
58. M.J. Loza, S. Foster, S.P. Peters, and R.B. Penn: Interactive effects of steroids and beta-agonists on accumulation of type 2 L cells. J Allergy Clin Immunol 121, 750-755(2008)
59. R.B. Penn: Embracing emerging pardigms of G protein-coupled receptor agonism and signaling to address airway smooth muscle pathobiology in asthma. Naunyn Schmiedebergs Arch Pharmacol 378, 149-169 (2008)
60. J. Oostendorp, D.S. Postma, H. Volders, H. Jongepier, H.F. Kauffman, H.M. Boezen, D.A. Meyers, E.R. Bleecker, S.A. Nelemans, J. Zaagsma, and H. Meurs: Differential desensitization of homozygous haplotypes of the beta2-adrenergic receptor in lymphocytes. Am J Respir Crit Care Med 172, 322-328 (2005) (Pubitemid 41026142)
61. L.P. Nguyen, R. Lin, S. Parra, O. Omoluabi, NA. Hanania, M.J. Luvim, B.J. Knoll, B.F. Dickey, and R.A. Bond: Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model. Proc Natl Acad Sci USA 106, 2435-2440 (2009)
62. K.M. Lorgersen, E.M. Aandahl, and K. Lasken: Molecular architecture of signal complexes regulating immune cell function. Handb Exp Pharmacol 327-363 (2008)
63. B.S. Skalhegg, K. Lasken, V. Hansson, H.S. Huitfeldt, L. Jahnsen, and L. Lea: Location of cAMP-dependent protein kinase type I with the LCR-CD3 complex. Science 263, 84-87(1994) (Pubitemid 24076260)
64. S.A. Solheim, E. Petsalaki, A.J. Stokka, R.B. Russell, K. Lasken, and L. Berge: Interactions between the Fyn SH3-domain and adaptor protein Cbp/PAG derived ligands, effects on kinase activity and affinity. FEBS J 275, 4863-4874 (2008)
65. K. Lasken, A. Ruppelt: Negative regulation of L-cell receptor activation by the cAMP-PKA-Csk signalling pathway in L-cell lipid rafts. Front Biosci 11, 2929-2939 (2006) (Pubitemid 43800386)
66. K.M. Lorgersen, J.L. Vaage, B. Rolstad, and K. Lasken: A soluble LAL deletion mutant inhibits L-cell activation: reduced recruitment of signalling molecules to glycolipid-enriched microdomains. Cell Signal 13, 213-220 (2001) (Pubitemid 32244406)
67. K.M. Lorgersen, L. Vang, H. Abrahamsen, S. Yaqub, V. Horejsi, B. Schraven, B. Rolstad, L. Mustelin, and K. Lasken: Release from tonic inhibition of L cell activation through transient displacement of C-terminal Src kinase (Csk) from lipid rafts. J Biol Chem 276, 29313-29318 (2001)